Literature DB >> 7868269

Differential activation of Brucella-reactive CD4+ T cells by Brucella infection or immunization with antigenic extracts.

Y Zhan1, A Kelso, C Cheers.   

Abstract

In order to induce acquired cellular resistance to facultative bacterial pathogens, infection with live organisms is required. We have previously demonstrated that spleen cells from Brucella-infected mice produced gamma interferon (IFN-gamma) and interleukin-2 (IL-2) in response to Brucella antigens in vitro, while spleen cells from mice immunized with soluble Brucella proteins (SBP) produced substantial amounts of IL-2 but no detectable amount of IFN-gamma. In this study, we further analyzed the response of T cells from Brucella-infected mice and SBP-immunized mice and demonstrated that CD4(+)-enriched cells from SBP-immunized mice also produced significant amounts of IL-4, which was not detected in bulk cultures of spleen cells from infected mice. Limiting dilution analysis showed that infection resulted in a higher precursor frequency of IFN-gamma-producing CD4+ T cells and a lower precursor frequency of IL-4-producing CD4+ T cells, while immunization with SBP resulted in a higher precursor frequency of IL-4-producing cells and a very low frequency of IFN-gamma-producing cells. The precursor frequencies of IL-2-producing cells for the two groups were similar. Furthermore, IFN-gamma-producing CD4+ T cells from infected donor mice were capable of mediating resistance against challenge infection in recipient mice, but IL-4-producing CD4+ T cells from immunized mice failed to do so. These results indicate that the form of antigen has a profound influence on the outcome of the immune response. The results are discussed in light of the supposed dichotomy between Th1 and Th2 cytokine responses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7868269      PMCID: PMC173097          DOI: 10.1128/iai.63.3.969-975.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  IFN-gamma-producing ability as a possible marker for the protective T cells against Mycobacterium bovis BCG in mice.

Authors:  I Kawamura; H Tsukada; H Yoshikawa; M Fujita; K Nomoto; M Mitsuyama
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

2.  The kinetics of emergence and loss of mediator T lymphocytes acquired in response to infection with Mycobacterium tuberculosis.

Authors:  I M Orme
Journal:  J Immunol       Date:  1987-01-01       Impact factor: 5.422

3.  Difference in the induction of macrophage interleukin-1 production between viable and killed cells of Listeria monocytogenes.

Authors:  M Mitsuyama; K Igarashi; I Kawamura; T Ohmori; K Nomoto
Journal:  Infect Immun       Date:  1990-05       Impact factor: 3.441

4.  Endogenous gamma interferon mediates resistance to Brucella abortus infection.

Authors:  Y Zhan; C Cheers
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

5.  Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages.

Authors:  C S Hsieh; S E Macatonia; C S Tripp; S F Wolf; A O'Garra; K M Murphy
Journal:  Science       Date:  1993-04-23       Impact factor: 47.728

6.  Allergen-dependent induction of interleukin-4 synthesis in vivo.

Authors:  X Yang; K T Hayglass
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

7.  Cytokine production in the murine response to brucella infection or immunization with antigenic extracts.

Authors:  Y Zhan; A Kelso; C Cheers
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

8.  Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines.

Authors:  I M Orme
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

9.  Interferon-gamma production by Listeria monocytogenes-specific T cells active in cellular antibacterial immunity.

Authors:  S H Kaufmann; H Hahn; R Berger; H Kirchner
Journal:  Eur J Immunol       Date:  1983-03       Impact factor: 5.532

10.  A cellular basis of immunity in experimental Brucella infection.

Authors:  J J HOLLAND; M J PICKETT
Journal:  J Exp Med       Date:  1958-09-01       Impact factor: 14.307

View more
  28 in total

1.  Immunization with a single dose of a microencapsulated Brucella melitensis mutant enhances protection against wild-type challenge.

Authors:  Angela M Arenas-Gamboa; Thomas A Ficht; Melissa M Kahl-McDonagh; Allison C Rice-Ficht
Journal:  Infect Immun       Date:  2008-03-24       Impact factor: 3.441

2.  Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK).

Authors:  D L Hoover; R M Crawford; L L Van De Verg; M J Izadjoo; A K Bhattacharjee; C M Paranavitana; R L Warren; M P Nikolich; T L Hadfield
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

Review 3.  Alternative strategies for vaccination to brucellosis.

Authors:  David W Pascual; Xinghong Yang; Hongbin Wang; Zakia Goodwin; Carol Hoffman; Beata Clapp
Journal:  Microbes Infect       Date:  2017-12-26       Impact factor: 2.700

4.  Subcellular fractions of Brucella ovis distinctively induce the production of interleukin-2, interleukin-4, and interferon-gamma in mice.

Authors:  E Salas-Téllez; A Núñez del Arco; V Tenorio; E Díaz-Aparicio; M de la Garza; F Suárez-Güemes
Journal:  Can J Vet Res       Date:  2005-01       Impact factor: 1.310

5.  Th1 and Th2 cell involvement in immune response to Salmonella typhimurium porins.

Authors:  M Galdiero; L De Martino; A Marcatili; I Nuzzo; M Vitiello; G Cipollaro de l'Ero
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

Review 6.  Brucellosis: an overview.

Authors:  M J Corbel
Journal:  Emerg Infect Dis       Date:  1997 Apr-Jun       Impact factor: 6.883

7.  The Brucella abortus S19 DeltavjbR live vaccine candidate is safer than S19 and confers protection against wild-type challenge in BALB/c mice when delivered in a sustained-release vehicle.

Authors:  A M Arenas-Gamboa; T A Ficht; M M Kahl-McDonagh; G Gomez; A C Rice-Ficht
Journal:  Infect Immun       Date:  2008-12-01       Impact factor: 3.441

8.  Endogenous interleukin-12 is involved in resistance to Brucella abortus infection.

Authors:  Y Zhan; C Cheers
Journal:  Infect Immun       Date:  1995-04       Impact factor: 3.441

9.  Intratracheal Inoculation with Brucella melitensis in the Pregnant Guinea Pig Is an Improved Model for Reproductive Pathogenesis and Vaccine Studies.

Authors:  Martha E Hensel; Sankar P Chaki; Lauren Stranahan; Anthony E Gregory; Erin J van Schaik; Daniel G Garcia-Gonzalez; Omar Khalaf; James E Samuel; Angela M Arenas-Gamboa
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

10.  Enhanced immune response of red deer (Cervus elaphus) to live rb51 vaccine strain using composite microspheres.

Authors:  Angela M Arenas-Gamboa; Thomas A Ficht; Donald S Davis; Philip H Elzer; Alfredo Wong-Gonzalez; Allison C Rice-Ficht
Journal:  J Wildl Dis       Date:  2009-01       Impact factor: 1.535

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.